Search

You searched for "PCR"

573 results found

Trabeculectomy with erroneous Mitomycin-C concentration – a near miss

1 April 2020 | | Ophthalmology, Glaucoma
Trabeculectomy is the most commonly performed surgical procedure for glaucoma in the United Kingdom and worldwide. Modifications to the technique have been made since its introduction in 1963, perhaps the most significant being the adjunctive use of mitomycin-C (MMC), which...

The power of the full blood count

1 October 2021 | | Ophthalmology, Retina / Uvea / Vitreous
Vishal Shah walks us through his thought process whilst highlighting the importance of routine investigations when dealing with unusual retinovascular presentations. Retinal changes can arise in anaemia, leukaemia, lymphoma, myeloproliferative and myelodysplastic syndrome. They are often the first manifestation of...

Optegra celebrates 15th anniversary and announces expansion plans

18 September 2023 | Optegra, MP, Angela Richardson, Eye Hospital, Anniversary, 15th
Specialist eye hospital Optegra marks its 15th anniversary this month, having opened its first UK hospital in Guildford in 2008.

The Lancet Global Health Commission on Global Eye Health: vision beyond 2020

2 August 2022 | | Ophthalmology
Introduction The Lancet Global Health Commission on Global Eye Health was published in 2021 [1]. Drawing on expertise from within and outside the eye health sector, the Commission set out to: inform governments and other stakeholders about the path forward...

ST3 Trainee experience of cataract surgery training in high flow settings in the independent sector

5 June 2023 | | Cataract and Refractive
As an ST3 trainee, I was provided with the opportunity to complete a surgical training rotation at Newmedica Middlesborough, which involved cataract training on NHS patients undergoing surgery in the independent sector (IS). This reflective account highlights the experience from...

The last three patients: dermatology (Patient Three)

3 August 2023 | | Dermatology
For the third and final reflection in this series (see Part 1 and Part 2), Professor Jonathan Rees recounts his experience of a patient with cancer who was failed by the NHS, and how their inadequate treatment illuminates some issues...

The clues of the eye – what is medical ophthalmology?

1 February 2022 |
The author looks at the increasingly significant role of medical ophthalmologists and the importance of integrative healthcare. The eye is a remarkable organ, and for decades we have been discovering intimations of pathology existing elsewhere in the body [1] simply...

The ‘art’ of refraction – designing a refraction course

1 April 2016 | | Cataract and Refractive
Learning how to refract requires theoretical knowledge, practice and determination. Refraction is a notoriously challenging skill to acquire and the competing demands on junior ophthalmologists can often be restrictive of the development of this core skill. To consolidate theory learnt...

Broadening horizons in ophthalmology: crafting a varied elective experience

24 January 2024 | | Ophthalmology, ONLINE EXCLUSIVE ARTICLES
The elective period for medical students is a unique opportunity to immerse oneself in a field of interest. For students interested in ophthalmology, this can offer a dedicated experience for what can otherwise be quite limited through undergraduate rotations. Alongside...

Evolving towards an interventional glaucoma mindset

2 February 2024 | | Glaucoma
Traditionally, a newly diagnosed glaucoma patient would be treated first with medical therapy. As the disease progressed or the initial intervention failed to adequately control intraocular pressure (IOP), clinicians would add more drops, selective laser trabeculoplasty (SLT), repeated SLT and...

RCOphth 2024 Preview

17 May 2024 |
Here is our annual highlights preview of the upcoming RCOphth 2024 Annual Congress in Belfast's ICC, 20-23 May.

Rare eye diseases: progress continues with authorised orphan medicines and breakthrough technologies

1 October 2018 | | Ophthalmology
An update on the development of orphan medicines, recent regulatory treatment approvals for rare eye conditions and advances in retinal prosthetic technologies for blinding diseases. The prevalence of a rare disease is based usually on a range of estimates and...